Literature DB >> 27163796

Understanding the value of cancer drugs-the devil is in the detail.

Daniel A Goldstein1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27163796     DOI: 10.1002/cncr.30044

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  2 in total

1.  Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Authors:  Omer Ben-Aharon; Racheli Magnezi; Moshe Leshno; Daniel A Goldstein
Journal:  Oncologist       Date:  2019-07-18

2.  Association of Immunotherapy With Durable Survival as Defined by Value Frameworks for Cancer Care.

Authors:  Omer Ben-Aharon; Racheli Magnezi; Moshe Leshno; Daniel A Goldstein
Journal:  JAMA Oncol       Date:  2018-03-01       Impact factor: 31.777

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.